Various methods categorize tumour response after neoadjuvant therapy, including down-
staging and tumour regression grading. Response categories allow comparison of different …

MRI is routinely used for rectal cancer staging to evaluate tumor extent and to inform
decision-making regarding surgical planning and the need for neoadjuvant and adjuvant …

Purpose Extramural venous invasion (EMVI) is recognized as a poor prognostic factor in
rectal cancer. There are well-documented limitations associated with pathology detection of …

The response to neoadjuvant chemoradiation (nCRT) is a critical step in the management of
locally advanced rectal cancer (LARC) patients. Only a minority of LARC patients responds …

More than 140,000 people in the United States are diagnosed annually with colorectal
cancer (CRC), and 5% to 40% of patients treated with curative intent develop a recurrence …

Abstract Purpose of Review This review aims to summarise the pathobiological role of
mesothelin and the current data on therapeutic antibodies targeting mesothelin in solid …

Background For patients with low-and intermediate-risk stage II/III rectal cancer, current
studies have reached a consensus that preoperative radiotherapy may be dispensed with …

Background Preoperative chemoradiotherapy (CRT) followed by surgery is the standard
treatment for locally advanced rectal cancer (LARC). We reported the short-term outcomes of …

Aim Total neoadjuvant treatment (TNT) is becoming standard in patients with locally
advanced rectal carcinoma (LARC). Preoperative chemoradiotherapy (CRT) has proven …

This study aimed to develop a nomogram based on the clinicopathological factors affecting
the prognosis of osteosarcoma patients to help clinicians predict the overall survival of …